Kjarninn - 22.08.2013, Side 112

Kjarninn - 22.08.2013, Side 112
“Not only are we averse to stressors, and don´t understand them, but we are committing crimes against life, the living, science, and wisdom, for the sake of eliminating volatility and variation. I feel anger and frustration when I thingk that one in ten Americans beyond the age of high school is on some kind of antidepressant, such as Prozac. Indeed, when you go through mood swings, you now have to justify why you are not on some medication. There may be a few good reasons to be on medications, in severely pathological cases, but my mood, my sadness, my bouts of anxiety, are a second source of intelligence­perhaps even the first source. I get mellow and lose physical energy when it rains, become more meditative, and tend to write more and more slowly then, with the raindrops hitting the window, what Verlaine called autumnal “sobs” Some days I enter poetic melancholic states, what the Portuguese call saudade or the Turks hüzün (from the Arabic word for sadness). Other days I am more aggressive, have more energy­and will write less, walk more, do other things, argue with researchers, answer emails, draw graphs on blackboards. Should I have turned into vegetable or a happy impecile? Had Prozac been available last century, Baudelaire's “spleen,” Edgar Allan Poe´s moods, the poetry of Sylvia Plath, the lamentations of so many other poets, everything wit a soul would have been silenced... If large pharmaceutical companies were able to eliminate the seasons, they would probably do so – for profit, of course. There is another danger: in additions to harming children, we are harming society and our future. Measures that aim at reducing variability and swings in the lives of children are also reducing variability and differences within our said to be Great Culturally Globalized Society. (Úr kaflanum Crimes against children, bls 61.) brot úr bóKinni Taleb hefur miklar áhyggjur af því að samfélagið vinni statt og stöðugt gegn óvissu og óreiðu og bæli niður eðlilegar skapsveiflur í boði lyfjafyrirtækjanna. 5/05 kjarninn ExIT
Side 1
Side 2
Side 3
Side 4
Side 5
Side 6
Side 7
Side 8
Side 9
Side 10
Side 11
Side 12
Side 13
Side 14
Side 15
Side 16
Side 17
Side 18
Side 19
Side 20
Side 21
Side 22
Side 23
Side 24
Side 25
Side 26
Side 27
Side 28
Side 29
Side 30
Side 31
Side 32
Side 33
Side 34
Side 35
Side 36
Side 37
Side 38
Side 39
Side 40
Side 41
Side 42
Side 43
Side 44
Side 45
Side 46
Side 47
Side 48
Side 49
Side 50
Side 51
Side 52
Side 53
Side 54
Side 55
Side 56
Side 57
Side 58
Side 59
Side 60
Side 61
Side 62
Side 63
Side 64
Side 65
Side 66
Side 67
Side 68
Side 69
Side 70
Side 71
Side 72
Side 73
Side 74
Side 75
Side 76
Side 77
Side 78
Side 79
Side 80
Side 81
Side 82
Side 83
Side 84
Side 85
Side 86
Side 87
Side 88
Side 89
Side 90
Side 91
Side 92
Side 93
Side 94
Side 95
Side 96
Side 97
Side 98
Side 99
Side 100
Side 101
Side 102
Side 103
Side 104
Side 105
Side 106
Side 107
Side 108
Side 109
Side 110
Side 111
Side 112
Side 113
Side 114
Side 115
Side 116
Side 117
Side 118
Side 119
Side 120
Side 121
Side 122
Side 123
Side 124
Side 125
Side 126
Side 127

x

Kjarninn

Direkte link

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Kjarninn
https://timarit.is/publication/958

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.